Now Available:
Dexcom G6 Pro

Healthcare professionals can
now order the Dexcom G6 Pro
Continuous Glucose Monitoring
(CGM) System for their clinics.

Discover Dexcom G6 Pro

Telehealth
Resources

Telehealth resources from
Dexcom can help
empower you to provide
patient care, anywhere.

LEARN MORE

COVID-19
Update

At this moment there are no interruptions
to Dexcom’s ability to produce and supply
product as a result of the coronavirus.

Learn More

Real-time
Continuous
Glucose
Data 24/7

The only provider of continuous
glucose monitors (CGMs) that give 
patients and their followers continuous
readings every five minutes, every day.

Read About Dexcom G6

Find Local
Pharmacy
Coverage for
Dexcom G6

Use our new online search tool to
quickly find coverage on the plans
your patients use most often.

Find Coverage

Prescribe
Dexcom CGM
Today

A retail pharmacy prescription can be 
the fastest and easiest way to start
your patients on a Dexcom Continuous
Glucose Monitor (CGM).*

*Participating pharmacies may vary by state.

Prescribe Dexcom G6

Powerful.
Proven.
Protective.

The smart iCGM solution for your
insulin-using patients.

Learn About Dexcom G6
Video

Doctor Testimonials
See All Videos

Dexcom-G6-Pro_Product_Family
Dexcom Telehealth Resources
COVID-19 Updates
Dexcom G6 Real-time CGM
Dexcom G6 Pharmacy Coverage Is Available
Prescribe Dexcom CGM Today
Powerful. Proven. Protective. Dexcom

Protective Features

Accuracy

Dexcom G6 features an overall MARD† of 9.0.1

RT-CGM

Real-time continuous glucose readings are sent straight to your patient's smart device* or receiver every five minutes.

More Followers

Glucose data can be shared with up to ten followers, increasing a patient's circle of support. Separate Follow App required.

Indicated for 2 Years
and Older

Dexcom is the only provider of CGM systems indicated for children ages 2 years and older.

Customizable Alerts

Two customized alert schedules can be set within a 24-hour period, giving patients more peace of mind and discretion, for example, while they are sleeping, exercising, or in a business meeting.

Urgent Low
Soon Alert

The Urgent Low Soon Alert can warn patients in advance of a potential severe hypoglycemic event (55 mg/dL or below)—allowing them time to take appropriate action before it happens.2

Dexcom_G6_CGM

View Dexcom Products

Proven Outcomes

Review the novel DIAMOND Study, as well as other clinical evidence
and professional society guidelines demonstrating the
benefits of Dexcom Continuous Glucose Monitoring (CGM).

See Clinical Evidence

Powerful Stories

Dr. Anita Swamy | Endocrinologist

Providers play a vital role in diabetes treatment, education, training and access to care for millions of Americans. Dexcom remains committed to helping empower providers with the best technology and resources for diabetes management. Hear why Endocrinologist Dr. Anita Swamy believes in Dexcom G6.

Dr. Swamy is a paid spokesperson of Dexcom, Inc.

See Story      See all Spotlights

Dr_Swamy

Dexcom News & Events

Oct 8 2019

Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM

First and only single-use, professional CGM system with blinded or unblinded mode Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for ...

Learn More

See all News and Events

*For a list of compatible devices, please visit dexcom.com/compatibility.
†MARD is a statistical measure of accuracy.
1Shah V LL, Wadwa P, et al. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technology and Therapeutics. 2018;20(6).
2Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA. Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert. Diabetes Technol Ther. 2019; 21(4):155-158.
3Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA. 2017; 317(4); 371-378.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.